Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly To Discuss Their Options ...

Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") of a class action securities ...

Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased Dentsply Sirona Inc. common stock between December 1, 2022 and November 6, 2024. Dentsply ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $18.85 which represents a slight increase of $0.24 or 1.29% from the prior close of $18.61. The stock opened at $18.51 and ...

NDAQ:XRAY) ROSEN, A LEADING LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRAY ...

Rising incidence of oral cancer along with an increase in the number of dental treatments is expected to propel the global ...

During his successful tenure at PepsiCo Canada, he held three Vice President roles and delivered exceptional results by ...

DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled ...

In a report released today, Allen Lutz from Bank of America Securities maintained a Hold rating on DENTSPLY SIRONA (XRAY – Research Report).

Fintel reports that on January 7, 2025, Evercore ISI Group downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from ...

Mizuho has recently initiated DENTSPLY SIRONA Inc (XRAY) stock to Neutral rating, as announced on December 4, 2024, according to Finviz. Earlier, on November 7, 2024, Leerink Partners had reduced the ...

DENTSPLY SIRONA (XRAY – Research Report) received a Hold rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...